-
Article
Open AccessPlasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study
Synaptic dysfunction is an early core feature of Alzheimer’s disease (AD), closely associated with cognitive symptoms. Neuregulin 1 (NRG1) is a growth and differentiation factor with a key role in the developm...
-
Article
Open AccessCSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
The presynaptic protein neuregulin1 (NRG1) is cleaved by beta-site APP cleaving enzyme 1 (BACE1) in a similar way as amyloid precursor protein (APP) NRG1 can activate post-synaptic receptor tyrosine-protein ki...
-
Article
Open AccessAre ketogenic diets promising for Alzheimer’s disease? A translational review
Brain amyloid deposition and neurofibrillary tangles in Alzheimer’s disease (AD) are associated with complex neuroinflammatory reactions such as microglial activation and cytokine production. Glucose metabolis...
-
Article
Open AccessPKR involvement in Alzheimer’s disease
Brain lesions in Alzheimer’s disease (AD) are characterized by Aβ accumulation, neurofibrillary tangles, and synaptic and neuronal vanishing. According to the amyloid cascade hypothesis, Aβ1-42 oligomers could...
-
Article
Open AccessUtility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study
Affective and psychotic disorders are mental or behavioural patterns resulting in an inability to cope with life’s ordinary demands and routines. These conditions can be a prodromal event of Alzheimer’s diseas...
-
Article
Open AccessNeuroinflammation and Aβ Accumulation Linked To Systemic Inflammation Are Decreased By Genetic PKR Down-Regulation
Alzheimer's disease (AD) is a neurodegenerative disorder, marked by senile plaques composed of amyloid-β (Aβ) peptide, neurofibrillary tangles, neuronal loss and neuroinflammation. Previous works have suggeste...
-
Article
Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study
CSF biomarkers of Alzheimer’s disease are well validated in clinical research; however, their pragmatic utility in daily practice is still unappreciated. These biomarkers are used in routine practice accordin...
-
Article
Open AccessNeuroprotective role of PKR in a model of neurodegeneration due to mild impairment of oxidative metabolism
-
Article
Open AccessPeripheral inflammation increases PKR activation, Tau phosphorylation and amyloid β production in wild-type mice